Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 6
Submit an article Journal homepage
460
Views
37
CrossRef citations to date
0
Altmetric
Theme: Hyper- & Hypo-tension - Review

The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review

Roberto Ferrari Department of Cardiology and LTTA Centre, University Hospital of Ferrara, Italy. [email protected]; Department of Cardiology and LTTA Centre, University Hospital of Ferrara, Italy. [email protected]
&
Eric Boersma Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
Pages 705-717 | Published online: 10 Jan 2014

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stefano Taddei. (2015) RAS inhibitors’ dose-dependent efficacy: myth or reality?. Current Medical Research and Opinion 31:7, pages 1245-1256.
Read now

Articles from other publishers (36)

Seok Oh, Ju Han Kim, Kyung Hoon Cho, Min Chul Kim, Doo Sun Sim, Young Joon Hong, Youngkeun Ahn & Myung Ho Jeong. (2023) Renin-Angiotensin-Aldosterone System Inhibitions and Cardiovascular Outcomes in Acute Myocardial Infarction With Renal Impairment. Mayo Clinic Proceedings.
Crossref
Suehyun Lee, Hyunah Kim, Hyeon Woo Yim, Kim Hun-Sung & Ju Han Kim. (2023) Comparison of cardiocerebrovascular disease incidence between angiotensin converting enzyme inhibitor and angiotensin receptor blocker users in a real-world cohort. Journal of Applied Biomedicine 21:1, pages 7-14.
Crossref
Lingyu Zhang, Jianyin Miao, Junbin Guo, Jie Liu, Zhen Xia, Bingbing Chen, Feng Ma & Yong Cao. (2023) Two Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from Rice ( Oryza sativa L. ) Bran Protein . Journal of Agricultural and Food Chemistry 71:9, pages 4153-4162.
Crossref
Amritha A. M., Shakhi Shylesh C. M., Kavyanjana R. Nair, Arya V. S., Thennavan Arumugam, Uma Devi P. & Kanthlal S. K.. (2022) Large Cardamom Extract Enhances Ramipril's Vasoprotective Action by Modulating Endothelial Redox Biology. An Evaluation based on in-silico and in-vitro Research. Current Computer-Aided Drug Design 18:6, pages 440-447.
Crossref
Pradeepika Chintha, Dipayan Sarkar, Kenneth Pecota, Munevver Dogramaci & Kalidas Shetty. (2021) Improving Phenolic Bioactive-Linked Functional Qualities of Sweet Potatoes Using Beneficial Lactic Acid Bacteria-Based Biotransformation Strategy. Horticulturae 7:10, pages 367.
Crossref
Francesca Fortini, Francesco Vieceli Dalla Sega, Luisa Marracino, Paolo Severi, Claudio Rapezzi, Paola Rizzo & Roberto Ferrari. (2021) Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 9:8, pages 997.
Crossref
Lu Xue, Rongxin Yin, Kate Howell & Pangzhen Zhang. (2021) Activity and bioavailability of food protein‐derived angiotensin‐I‐converting enzyme–inhibitory peptides. Comprehensive Reviews in Food Science and Food Safety 20:2, pages 1150-1187.
Crossref
Xiao-Chun Yang, Li-Li Shao, Ying-Jun Mi, Wen-Hao Zhang, Nuo-Ya Liu, Ruo-Bin Liu, Xiao-Xi Zhou, Wei-Hong Zhang & Qing-Bao Tian. (2021) Effect of renin-angiotensin-aldosterone system inhibitors on all-cause mortality and major cardiovascular events in patients with diabetes: A meta-analysis focusing on the number needed to treat and minimal clinical effect. Journal of Diabetes and its Complications 35:3, pages 107830.
Crossref
Rishi Trikha, Danielle Greig, Benjamin V. Kelley, Zeinab Mamouei, Troy Sekimura, Nicolas Cevallos, Thomas Olson, Ameen Chaudry, Clara Magyar, Daniel Leisman, Alexandra Stavrakis, Michael R. Yeaman & Nicholas M. Bernthal. (2020) Inhibition of Angiotensin Converting Enzyme Impairs Anti-staphylococcal Immune Function in a Preclinical Model of Implant Infection. Frontiers in Immunology 11.
Crossref
Gabriel Lucca de Oliveira Salvador. 2020. Selected Chapters from the Renin-Angiotensin System. Selected Chapters from the Renin-Angiotensin System.
Jeayoun Kim, Jungchan Park, Jong-Hwan Lee, Jeong Jin Min, Seung-Hwa Lee, Young Tak Lee, Wook Sung Kim, Sanghoon Song, Jung Hyun Yeo & Hyojin Cho. (2020) Comparative Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Coronary Artery Bypass Grafting. Scientific Reports 10:1.
Crossref
In Suck Choi, Ie Byung Park, Kiyoung Lee, Tae Hoon Ahn, Ju Han Kim, Youngkeun Ahn, Sung-Chull Chae, Hyo-Soo Kim, Young Jo Kim, Myeong Chan Cho, Chong Jin Kim, Myung Ho Jeong & Dae Ho Lee. (2018) Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge. Journal of Cardiovascular Pharmacology and Therapeutics 24:2, pages 120-129.
Crossref
Seyed Hamidreza Mahmoudpour, Folkert W. Asselbergs, Patrick C. Souverein, Anthonius de Boer & Anke H. Maitland-van der Zee. (2018) Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study. British Journal of Clinical Pharmacology 84:10, pages 2365-2372.
Crossref
Jae Kyeong Byun, Byoung Geol Choi, Seung-Woon Rha, Se Yeon Choi & Myung Ho Jeong. (2018) Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention. Atherosclerosis 277, pages 130-135.
Crossref
Csaba András Dézsi. (2018) Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study. Journal of International Medical Research 46:5, pages 1902-1909.
Crossref
Martin H. Strauss & Alistair S. Hall. (2018) The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes Mellitus. Canadian Journal of Diabetes 42:2, pages 124-129.
Crossref
Naim Kittana. (2018) Angiotensin-converting enzyme 2-Angiotensin 1-7/1-9 system: novel promising targets for heart failure treatment. Fundamental & Clinical Pharmacology 32:1, pages 14-25.
Crossref
Gabriel LO Salvador, Vinicius M Marmentini, Willian R Cosmo & Emilton L Junior. (2017) Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis. European Journal of Preventive Cardiology 24:18, pages 1914-1924.
Crossref
Berhe W. Sahle, Alice J. Owen, Lindon M.H. Wing, Lawrence J. Beilin, Henry Krum & Christopher M. Reid. (2017) Long-term survival following the development of heart failure in an elderly hypertensive population. Cardiovascular Therapeutics 35:6, pages e12303.
Crossref
Kateřina Študentová. (2017) Primary detection of arterial hypertension in a patient with a risk history. Medicína pro praxi 14:4, pages 207-211.
Crossref
Karim Fazal, Gayan Perera, Mizanur Khondoker, Robert Howard & Robert Stewart. (2018) Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease. BJPsych Open 3:4, pages 158-164.
Crossref
Martin H. StraussAlistair S. Hall. (2017) Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox. Circulation 135:22, pages 2088-2090.
Crossref
Roberto Federico Villa, Federica Ferrari & Antonio Moretti. 2017. Neuroprotective Therapy for Stroke and Ischemic Disease. Neuroprotective Therapy for Stroke and Ischemic Disease 349 399 .
Csaba András Dézsi & Veronika Szentes. (2016) Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk. American Journal of Cardiovascular Drugs 16:6, pages 399-406.
Crossref
Fabrizio Ricci, Augusto Di Castelnuovo, Gianluigi Savarese, Pasquale Perrone Filardi & Raffaele De Caterina. (2016) ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure — A network meta-analysis. International Journal of Cardiology 217, pages 128-134.
Crossref
Xavier Humbert, Sophie Fedrizzi, Joachim Alexandre, Paolo-Emilio Puddu, Antoine Coquerel, Jean-Charles Robert & Lydia Guittet. (2016) Is ACE–inhibitors cough a difficult diagnosis? 1100 general practitioners replies from four countries. European Journal of Internal Medicine 32, pages e17-e18.
Crossref
Jaroslav Brotánek. (2016) A patient with hypertension and high cardiovascular risk. Medicína pro praxi 13:2, pages 83-88.
Crossref
Fu-Chih Hsiao, Ying-Chang Tung, Shing-Hsien Chou, Lung-Sheng Wu, Chia-Pin Lin, Chun-Li Wang, Yu-Sheng Lin, Chee-Jen Chang & Pao-Hsien Chu. (2015) Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension. Medicine 94:51, pages e2355.
Crossref
Seyed Hamidreza Mahmoudpour, Folkert W. Asselbergs, Catherine E. de Keyser, Patrick C. Souverein, Albert Hofman, Bruno H. Stricker, Anthonius de Boer & Anke-Hilse Maitland-van der Zee. (2015) Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors. International Journal of Clinical Pharmacy 37:6, pages 1095-1103.
Crossref
Kaitlin H Wade, David Carslake, Tom Ivar Nilsen, Nicholas J Timpson, George Davey Smith & Pål Romundstad. (2015) Blood pressure and mortality: using offspring blood pressure as an instrument for own blood pressure in the HUNT study. Scientific Reports 5:1.
Crossref
Claudio Borghi, Martino Morbini & Arrigo F.G. Cicero. (2015) Combination therapy in the extended cardiovascular continuum. Journal of Cardiovascular Medicine 16:5, pages 390-399.
Crossref
William J. Elliott. (2015) Rationale for a single-pill combination of perindopril arginine and amlodipine besylate. Journal of the American Society of Hypertension 9:4, pages 257-265.
Crossref
Anthony M. SzemaSophia DangJonathan C. Li. (2015) Emerging Novel Therapies for Heart Failure. Clinical Medicine Insights: Cardiology 9s2, pages CMC.S29735.
Crossref
Sanya Roysommuti, Angkana Kritsongsakchai & J. Michael Wyss. 2015. Taurine 9. Taurine 9 665 677 .
Ilaria Spoletini, Cristiana Vitale & Giuseppe M. C. Rosano. 2015. ACEi and ARBS in Hypertension and Heart Failure. ACEi and ARBS in Hypertension and Heart Failure 119 148 .
T. A. Netchessova, A. P. Shepelkevich & T. V. Gorbat. (2013) Efficacy of Single-Pill Perindopril/Indapamide in Patients with Hypertension and Type 2 Diabetes. High Blood Pressure & Cardiovascular Prevention 21:1, pages 63-69.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.